Literature DB >> 10188007

Psychometric evaluation of daytime sleepiness and nocturnal sleep onset scales in a representative community sample.

E O Johnson1, N Breslau, T Roth, T Roehrs, L Rosenthal.   

Abstract

BACKGROUND: The public health importance of daytime sleepiness as a risk factor for accidents, interpersonal problems, and decreased productivity has been recognized. However, epidemiologic research on this topic has been limited by the reliance on laboratory measures (i.e., the Multiple Sleep Latency Test-MSLT). Two scales, daytime sleepiness and nocturnal sleep onset, have been identified from the self-report Sleep-Wake Activity Inventory (SWAI) in a clinic sample and validated against the MSLT. This study evaluates the replicability of the two scales in a population sample and assesses potential thresholds in scale scores that distinguish normal from pathologic levels of daytime sleepiness and difficulty falling asleep.
METHODS: The sample consisted of 2181 subjects 18-45 years old in the Detroit metropolitan area. All sleep characteristic information covered the 2 weeks prior to interview. Split-half sample factor analyses were conducted to assess replicability of the results. Distribution of scale scores and their relation to construct validity variables were used to evaluate possible thresholds.
RESULTS: A two-factor model appeared to best account for the variation among the 12 items from the SWAI. The two factors accounted for 50% of the variance in both split-half sample analyses. The revised eight-item daytime sleepiness and two-item nocturnal sleep onset scales showed good and fair internal consistency respectively across both split-half samples. There appeared to be a "natural break" in daytime sleepiness scale scores that was associated with a substantial and consistent change in number of hours slept. No breaks appeared in nocturnal sleep onset scores.
CONCLUSIONS: This study replicated the results of the clinic-based study and suggested a potentially useful diagnostic threshold for self-report excessive daytime sleepiness. Epidemiology of sleep depends on the ability to move from the laboratory to population surveys in reliable and valid ways. Development of self-report is a step in that direction.

Entities:  

Mesh:

Year:  1999        PMID: 10188007     DOI: 10.1016/s0006-3223(98)00111-5

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness.

Authors:  Christopher Drake; Timothy Roehrs; Naomi Breslau; Eric Johnson; Catherine Jefferson; Holly Scofield; Thomas Roth
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

Review 2.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

Authors:  Jennifer P Schneider; Michele Matthews; Robert N Jamison
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

Review 4.  Sleep problems in the child with attention-deficit hyperactivity disorder: defining aetiology and appropriate treatments.

Authors:  Margaret D Weiss; Jay Salpekar
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

5.  Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences.

Authors:  Holly Scofield; Thomas Roth; Christopher Drake
Journal:  Sleep       Date:  2008-09       Impact factor: 5.849

6.  Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.

Authors:  Olivier Andlauer; Hyatt Moore; Laura Jouhier; Christopher Drake; Paul E Peppard; Fang Han; Seung-Chul Hong; Francesca Poli; Giuseppe Plazzi; Ruth O'Hara; Emmanuel Haffen; Thomas Roth; Terry Young; Emmanuel Mignot
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

7.  The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease.

Authors:  Martina Minnerop; Bernd Weber; Jan-Christoph Schoene-Bake; Sandra Roeske; Sandra Mirbach; Christian Anspach; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Thomas Klockgether; Cornelia Kornblum
Journal:  Brain       Date:  2011-11-29       Impact factor: 13.501

8.  Tracking the brain in myotonic dystrophies: A 5-year longitudinal follow-up study.

Authors:  Carla Gliem; Martina Minnerop; Sandra Roeske; Hanna Gärtner; Jan-Christoph Schoene-Bake; Sandra Adler; Juri-Alexander Witt; Felix Hoffstaedter; Christiane Schneider-Gold; Regina C Betz; Christoph Helmstaedter; Marc Tittgemeyer; Katrin Amunts; Thomas Klockgether; Bernd Weber; Cornelia Kornblum
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

Review 9.  Antidepressant drugs for narcolepsy.

Authors:  L Vignatelli; R D'Alessandro; L Candelise
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.